Latest Breaking News On - Aboutqualigentherapeutics inc - Page 4 : comparemela.com

Qualigen Therapeutics Appoints Shishir Sinha to Lead Diagnostics Division Following Promotion to Senior Vice President

Qualigen Therapeutics Appoints Shishir Sinha to Lead Diagnostics Division Following Promotion to Senior Vice President
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shishir sinhaMichael poirierExchange commissionJules abrahamjqa partners incQualigen therapeutics incAboutqualigentherapeutics incOrphan drug designationSenior vice presidentChief operating officerChief executive officerQualigen therapeuticsSekisui diagnosticsFast trackOrphan drugPrivate securities litigation reform act

Qualigen Therapeutics Engages TD2 as Contract Research Organization for Preclinical Development of QN-302

Qualigen Therapeutics Engages TD2 as Contract Research Organization for Preclinical Development of QN-302
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesJules abrahamStephen gatelyTariq arshadExchange commissionPartners incTranslational drug developmentQualigen therapeutics incAboutqualigentherapeutics incQualigen therapeuticsOrphan drug designationChief medicalFast trackOrphan drugPrivate securities litigation reform act

Peer-Reviewed Article Confirms That Qualigen s FastPack® is as Accurate in Thyroid Stimulating Hormone Measurement - and Much Faster - Than a Leading Laboratory Method

Peer-Reviewed Article Confirms That Qualigen s FastPack® is as Accurate in Thyroid Stimulating Hormone Measurement - and Much Faster - Than a Leading Laboratory Method
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Tony schorDavid kugelmanMichael poirierAtlanta capital partnersQualigen therapeutics incAboutqualigentherapeutics incExchange commissionCompany pointBeckman coulterInvestor awareness incQualigen therapeuticsOrphan drug designationChief executiveEmerging point of care toolCentralized laboratory based methodLee lipski